Advances in the management of cutaneous T-cell lymphoma

Dermatologic Clinics

Volumn 16, Issue 2, 1998, Pages 301-311

  Sinha, A A ^a   Heald, P ^a  

^a LCI 500   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEXAROTENE; CYTOKINE; PADGEM PROTEIN; RETINOID;

BINDING AFFINITY; CANCER CHEMOTHERAPY; CELL MATURATION; HUMAN; IMMUNOBIOLOGY; MYCOSIS FUNGOIDES; PHOTODYNAMICS; PRIORITY JOURNAL; REVIEW; SKIN CANCER; SKIN LYMPHOMA; T CELL LYMPHOMA; TREATMENT PLANNING; VACCINATION;

EID: 0031925578     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8635(05)70012-7     Document Type: Article

References (65)

1. M. Bagot J. Wechsler M.C. Lescs Intraepidermal localization of the clone in cutaneous T-cell lymphoma J Am Acad Dermatol 27 1992 589
2. J.C. Bass N.T. Korobkin K.D. Cooper Cutaneous T-cell lymphoma: CT in evaluation and staging Radiol 186 1993 273
3. C.L. Berger J. Chien R. Edelson BE2 antigen may represent or be associated with a heat shock protein membrane molecule [abstract] J Invest Dermatol 100 1993 563
4. W.H. Boehncke K. Konig A. Ruch In vitro and in vivo effects of photodynamic therapy in cutaneous T cell lymphoma Acta Derm Venereol 74 1994 201
5. A. Bourguin R. Tung N. Galili Rapid nonradioactive detection of clonal T-cell receptor rearrangements in lymphoid neoplasms Proc Natl Acad Sci USA 87 1990 8536
6. T. Breitman S. Selonic S. Collins Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid Proc Natl Acad Sci USA 77 1980 2936
7. W.E. Clendenning Brecher E.J. Van Scott Mycosis fungoides—relationship to malignant cutaneous reticulosis and the Sezary syndrome Arch Dermatol 89 1964 785
8. A.M. D'Andrea N.M. Aste-Amezaga S. Valiante Interleukin-10 inhibits human lymphocyte IFN γ production by suppressing natural killer cell stimulatory factor/interleukin-12 synthesis in accessory cells J Exp Med 178 1993 1041
9. R. Evans The steroid and thyroid hormone receptor superfamily Science 240 1988 889
10. D.P. Fivensen C.A. Hanson B.J. Nickoloff Localization of clonal T cells to the epidermis in cutaneous T-cell lymphoma J Am Acad Dermatol 31 1994 717
11. M. Girardi P. Heald Extracorporeal photochemotherapy G. Burg R. Dummer Immunointerventions in Dermatology 1997 Springer Verlag Berlin
12. R.E. Hawkins G. Winter T.G. Homblin A genetic approach to idiotypic vaccination J Immunother 14 1993 273
13. P.W. Heald R.L. Edelson Cutaneous lymphomas T. Fitzpatrick A. Eisen K. Wolff Dermatology in General Medicine 1997 McGraw Hill New York
14. P. Heald R. Knobler L. LaRoche Photoinactivated lymphocyte therapy of cutaneous T-cell lymphoma Dermatol Clin 12 1994 443
15. P. Heald S.L. Yan C. Berger Profound deficiency in normal circulating T-cells in erythrodermic cutaneous T-cell lymphoma Arch Dermatol 130 1994 198 203
16. P. Heald S.L. Yan R.L. Edelson Skin selective lymphocyte homing mechanisms in the pathogenesis of leukemic cutaneous T-cell lymphoma J Invest Dermatol 101 1993 222
17. W.K. Hong J. Endicott L.M. Itri 13- cis -retinoic acid in the treatment of oral leukoplakia N Engl J Med 315 1986 1501
18. W. Hong S. Lippman L. Itri Prevention of secondary primary tumor with isotretinoin in squamous cell carcinoma of the head and neck N Engl J Med 323 1990 795
19. R.T. Hoppe L.J. Medeiros R.A. Warnke CD8 positive tumor infiltrating lymphocytes influence the long term survival of patients with mycosis fungoides J Am Acad Dermatol 32 1995 448
20. F.J. Hsu C. Benike F. Fagnoni Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells Nat Med 2 1996 52
21. T. Huang Y. Ye S. Chen Use of trans -retinoic acid in the treatment of acute promyelocytic leukemia Blood 72 1988 567
22. D. Kieffer R. Fuhlbrigge D. Amerding Molecular identification of cutaneous lymphocyte associated antigen (CLA): CLA is an isoform of P selectin glycoprotein [abstract] J Invest Dermatol 108 1997 555
23. Y.H. Kim R.A. Jensen G.L. Watanabe Clinical stage IA (limited patch and plaque) mycosis fungoides: A long-term outcome analysis Arch Dermatol 132 1996 1309
24. M. Kobayashi L. Fitz R.M. Hewick Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes J Exp Med 170 1989 827
25. M. Leid P. Kastner P. Chambon Multiplicity generates diversity in the retinoic acid signaling pathways TIBS 17 1992 427
26. 486 IL-2 in hematological cancers Cancer Res 53 1993 3030
27. S.R. Lessin F.E. Fox G. Li T-cell receptor DNA vaccination in cutaneous T-cell lymphoma [abstract] J Invest Dermatol 108 1997 571
28. G. Li A.H. Rook S.R. Lessin The arteriolymphatic circulation of cutaneous T cell lymphoma [abstract] J Invest Dermatol 108 1997 636
29. O. Lider T. Reshef E. Beraud Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis Science 239 1988 181
30. S. Lippman J. Kavanagh M. Paredes-Espinoza 13- cis -Retinoic acid plus interferon-alpha-2a: Highly active systemic therapy for squamous cell carcinoma of the cervix J Natl Cancer Inst 84 1992 235
31. J.W. Lowenthal H.R. Macdonald B.J. Iacopetta Intracellular pathway of interleukin 2 following receptor-mediated endocytosis Eur J Immunol 16 1986 1461
32. J.W. Lynch I. Linoilla E.A. Sausville Prognostic implications of evaluation for lymph node involvement by T-cell antigen receptor gene rearrangement in mycosis fungoides Blood 79 1992 3293
33. J.P. Marolleau M. Baccard B. Flageul High-dose recombinant interleukin-2 in advanced cutaneous T-cell lymphoma Arch Dermatol 131 1995 574
34. S. Martin J. Bradley T. Cotter HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosis Clin Exp Immunol 79 1990 448
35. W.M. McDonnell F.K. Askari DNA vaccines N Engl J Med 334 1996 42
36. E.N. Mostow S.L. Neckel L. Oberhelman Complete remissions in psoralen and UV-A (PUVA) refractory mycosis fungoides-type cutaneous T-cell lymphoma with combined interferon alfa and PUVA Arch Dermatol 129 1993 747
37. T.R. Mosmann H. Cherwinski M.W. Bond Two types of murine helper T-cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins J Immunol 136 1986 2348
38. B.J. Nickoloff C. Griffiths Intraepidermal but not dermal T-lymphocytes are positive for cell-cycle associated antigen Ki-67 in mycosis fungoides Am J Pathol 136 1990 261
39. H. Offner G.A. Hashim A.A. Vandenbark T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis Science 251 1991 430
40. L.J. Picker T.K. Kishimoto C.W. Smith ELAM-1 is an adhesion molecule for skin-homing T cells Nature 349 1991 796
41. L.J. Picker S.A. Michie L.S. Rott A unique phenotype of skin associated lymphocytes in humans: Preferential expression of the HECA-452 epitope by benign and malignant T cells at cutaneous sites Am J Pathol 136 1990 1053
42. K. Rittenhouse-Diakun H. van Leengoed J. Morgan The role of transferrin receptor (CD71) in photodynamic therapy of activated and malignant lymphocytes using the heme precursor δ-aminolevulinic acid (ALA) Photochem Photobiol 61 1995 523 528
43. A.H. Rook S.L. Gottlieb J.T. Wolfe Pathogenesis of cutaneous T-cell lymphoma: Implications for the use of recombinant cytokines and photopheresis Clin Exp Immunol 107 Suppl 1997 16
44. A. Rook P. Heald The immunopathogenesis of cutaneous T-cell lymphoma Hematol Oncol Clin North Am 9 1995 997
45. A.H. Rook M. Kubin M. Cassin Interleukin 12 reverses cytokine and immune abnormalities in Sezary syndrome J Immunol 154 1995 1491
46. A. Savin C.J. Carrera D.A. Carson 2Chlorodeoxyadenosine: An active agent in the treatment of cutaneous T-cell lymphoma Blood 80 1993 587
47. R.A. Spooner M.P. Deonariain A.A. Epenetos DNA vaccination for cancer treatment Gene Therapy 2 1995 173
48. M. Sporn A. Roberts Role of retinoids in differentiation and carcinogenesis J Natl Cancer Inst 73 1984 1381
49. K. Svanberg T. Anderson D. Killander Photodynamic therapy of non-melanoma malignant tumours of the skin using topical δ-amino levulinic acid sensitization and laser irradiation Br J Dermatol 130 1994 743
50. T. Takeshita H. Asao K. Ohtani Cloning of the γ chain of the IL-2 receptor Science 257 1987 75
51. J.R. Toro H.L. Stoll P.C. Stomper Prognostic factors and evaluation of mycosis fungoides and Sezary syndrome J Am Acad Dermatol 37 1997 58
52. P. Tu S. Miyauchi Y. Milki Proliferative activity of epidermal and dermal T lymphocytes in mycosis fungoides Dermatology 189 1994 354
53. D.T. Umetsu H.H. Jabara R.H. DeKruyff Functional heterogeneity among human inducer T cell clones J Immunol 140 1988 4211
54. H. Veelken G.S. Wood J. Sklar Molecular staging of cutaneous T-cell lymphoma. Evidence for systemic involvement in early disease J Invest Dermatol 104 1995 889
55. E.C. Vonderheid L.W. Diamond W.A. van Vloten Lymph node classification systems in cutaneous T-cell lymphoma: Evidence for the utility of the working formulation of non-Hodgkin's lymphomas for clinical usage Cancer 73 1994 207
56. E.C. Vonderheid E. Tan E.L. Sobel Clinical implications of immunologic phenotyping in cutaneous T cell lymphoma J Am Acad Dermatol 17 1987 40
57. B.R. Vowels M. Cassin E.C. Vonderheid Aberrant cytokine production by Sezary syndrome patients: Cytokine secretion pattern resembles murine Th2 cells J Invest Dermatol 99 1992 90
58. T.A. Waldmann The structure, function, and expression of interleukin-2 receptors on normal and malignant lymphocytes Science 232 1986 727 731
59. T.A. Waldmann C.K. Goldman R.J. Robb Expression of interleukin 2 receptors on activated human B cells J Exp Med 160 1984 1460
60. R.P. Warrell S.R.I. Franke W.H. Miller Differentiation therapy of acute promyelocytic leukemia with tretinoin (all trans -retinoic acid) N Engl J Med 324 1991 1385
61. 486IL-2): Fragment B sequences required for the delivery of fragment A to the cytosol of target cells J Biol Chem 265 1990 11885
62. L.D. Wilson A.L. Licata I.M. Braverman Systemic chemotherapy and extracorporeal photochemotherapy for T3 and T4 cutaneous T-cell lymphoma patients who have achieved a complete response to total skin electron beam therapy Int J Radiat Oncol Biol Phys 32 1995 987
63. G.S. Wood R.M. Tung C.F. Crooks Detection of early cutaneous T cell lymphoma J Invest Dermatol 103 1994 34
64. H.S. Zackheim M.K. Sabet S.T. Hwang Low dose methotrexate to treat erythrodermic cutaneous T-cell lymphoma: Results in twenty nine patients J Am Acad Dermatol 34 1996 626
65. J. Zic C. Arzubiaga K.E. Salhany Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma J Am Acad Dermatol 27 1992 729